Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

15.0K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
15.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of Nanobodies against Tetramethylenedisulfotetramine by Integrating Next-Generation Sequencing and Moderate Random Mutagenesis.

Analytical chemistry·2026
Same author

β,β-Dimethylacrylalkannin Restores Colistin Efficacy Against <i>mcr</i>- and TCS-Mediated Resistant Gram-Negative Bacteria via Membrane Disturbance.

Antibiotics (Basel, Switzerland)·2026
Same author

Development of monoclonal antibody and immunoassays for determination of florylpicoxamid in foods: A sub-similarity principle for guiding the hapten design.

Journal of hazardous materials·2026
Same author

Selection and characterization of a DNA aptamer for Patulin and its application in a label-free fluorescence assay for fruit juices.

One health advances·2025
Same author

Economic burden of carbapenem-resistant Klebsiella pneumoniae infections in Chinese hospitals: A 2019 analysis.

Journal of global antimicrobial resistance·2025
Same author

mgrB inactivation confers enhanced pathogenicity and immune evasion over mcr-1 expression in colistin-resistant Klebsiella pneumoniae.

Microbiological research·2025

Related Experiment Video

Updated: Jul 24, 2025

Cell Electrofusion Visualized with Fluorescence Microscopy
05:02

Cell Electrofusion Visualized with Fluorescence Microscopy

Published on: July 1, 2010

14.2K

Advances in hybridoma preparation using electrofusion technology.

Jiaqian Kou1,2, Jianzhong Shen1,2, Zhanhui Wang1,2

  • 1National Key Laboratory of Veterinary Public Health Security, College of Veterinary Medicine, China Agricultural University, Beijing Key Laboratory of Detection Technology for Animal-Derived Food Safety, and Beijing Laboratory for Food Quality and Safety, Beijing, People's Republic of China.

Biotechnology Journal
|July 4, 2023
PubMed
Summary

Cell electrofusion offers a promising alternative to traditional methods for hybridoma preparation. This review details advancements in electrofusion instruments and techniques for optimizing hybridoma cell fusion.

Keywords:
cell engineeringelectrofusionhybridomamonoclonal antibody

More Related Videos

Generation of Murine Monoclonal Antibodies by Hybridoma Technology
09:42

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

41.9K
Generation of Monoclonal Antibodies Against Natural Products
12:15

Generation of Monoclonal Antibodies Against Natural Products

Published on: April 6, 2019

11.0K

Related Experiment Videos

Last Updated: Jul 24, 2025

Cell Electrofusion Visualized with Fluorescence Microscopy
05:02

Cell Electrofusion Visualized with Fluorescence Microscopy

Published on: July 1, 2010

14.2K
Generation of Murine Monoclonal Antibodies by Hybridoma Technology
09:42

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

41.9K
Generation of Monoclonal Antibodies Against Natural Products
12:15

Generation of Monoclonal Antibodies Against Natural Products

Published on: April 6, 2019

11.0K

Area of Science:

  • Biotechnology and Cell Engineering
  • Immunology and Hybridoma Technology

Background:

  • Cell electrofusion is an emerging technique for hybridoma preparation.
  • Current limitations include high operational demands, instrument costs, and a lack of established protocols compared to polyethylene glycol (PEG)-mediated fusion.

Purpose of the Study:

  • To review the current state of cell electrofusion in hybridoma preparation.
  • To identify key challenges and provide insights for future development.

Main Methods:

  • Literature review focusing on electrofusion instruments, process control, and cell treatment.
  • Analysis of recent published research on electrofusion for hybridoma applications.

Main Results:

  • Electrofusion instruments and their components are critical for successful application.
  • Optimization of electrical parameters and precise cell control remain significant challenges.
  • Recent advancements offer potential solutions for overcoming current limitations.

Conclusions:

  • Cell electrofusion shows significant potential for hybridoma preparation but requires further refinement.
  • Addressing challenges in instrumentation, parameter optimization, and cell handling is crucial for wider adoption.